HOOVER LAB
AT
BRIGHAM & WOMEN'S HOSPITAL

HOOVER LAB AT BRIGHAM & WOMEN'S HOSPITALHOOVER LAB AT BRIGHAM & WOMEN'S HOSPITALHOOVER LAB AT BRIGHAM & WOMEN'S HOSPITAL
  • Home
  • ABOUT
  • RESEARCH FOCUS
  • OUR TEAM
  • SELECTED PUBLICATIONS
  • SUPPORT
  • CONTACT
  • More
    • Home
    • ABOUT
    • RESEARCH FOCUS
    • OUR TEAM
    • SELECTED PUBLICATIONS
    • SUPPORT
    • CONTACT

HOOVER LAB
AT
BRIGHAM & WOMEN'S HOSPITAL

HOOVER LAB AT BRIGHAM & WOMEN'S HOSPITALHOOVER LAB AT BRIGHAM & WOMEN'S HOSPITALHOOVER LAB AT BRIGHAM & WOMEN'S HOSPITAL
  • Home
  • ABOUT
  • RESEARCH FOCUS
  • OUR TEAM
  • SELECTED PUBLICATIONS
  • SUPPORT
  • CONTACT

Autoimmune Disease Research at the Hoover Laboratory

Autoimmune Disease Research at the Hoover LaboratoryAutoimmune Disease Research at the Hoover LaboratoryAutoimmune Disease Research at the Hoover Laboratory

ABOUT OUR LAB

Overview

Welcome to the Hoover Lab — a translational research lab in the Division of Rheumatology, Inflammation, & Immunity at Brigham and Women’s Hospital and Harvard Medical School in Boston. Based in the Hale Building for Transformative Medicine in Longwood, we combine cutting-edge technology with clinical access to drive discoveries that translate into new therapies for autoimmune disease.


Our facility includes a cellular profiling hub (single-cell droplet and spatial transcriptomics), flow cytometry, histopathology, molecular imaging, and a mouse vivarium—tools that empower high-resolution study of immune cells in human tissue and preclinical models. We emphasize interdisciplinary collaboration with direct links to Brigham patient clinics and Harvard Medical School investigators.


Mission 

We pursue a bed-to-bench translational strategy to identify and validate novel therapeutic targets in autoimmune diseases, with a focus on macrophage-driven mechanisms of tissue injury and repair in lupus nephritis and rheumatoid arthritis. Our goal is to reveal actionable biology that accelerates next-generation drug development.

RESEARCH FOCUS

Erlenmeyer flask with orange liquid in a lab setting with microscope and test tubes.

The role of myeloid cells in tissues affected by autoimmunity

  • Our lab investigates immune responses that drive tissue injury and repair in autoimmune diseases, with a primary focus on kidney and synovial tissues. We concentrate on macrophages and related myeloid populations to define how distinct cellular states promote damage or support regeneration.


  • Lupus nephritis. We have deeply profiled human and mouse kidneys affected by lupus and identified a disease-associated macrophage subset that correlates with progressive tissue injury. Current work aims to define the signals that drive cellular differentiation and function, determine their role in disease progression, and reveal how they modulate local injury and repair programs with the goal of translating these insights into targetable interventions.


  • Rheumatoid arthritis. We study macrophage heterogeneity in inflamed synovium to understand which subsets perpetuate inflammation versus those that promote resolution and repair. In collaboration with the Gravallese and Jacome‑Galarza labs at BWH, we are mapping macrophage phenotypes and mechanisms that control joint damage and repair, seeking pathways amenable to therapeutic modulation.

Our approach

  • We use methodologies such as single-cell and spatial technologies, genomic perturbations, and cellular immunologic approaches to study autoimmune diseases, including lupus nephritis and rheumatoid arthritis. We start by profiling and studying tissue and immune cells from patient samples to reveal cellular and molecular targets linked to immune and tissue dysregulation. We then utilize both human samples, primary cultures, and mouse models to dissect the role of these potential therapeutic targets.

OUR TEAM

Paul Hoover, MD PhD Principal Investigator

Wonhee Han, PhD Post-doctoral scholar

Wonhee Han, PhD Post-doctoral scholar

Professional man in a blue suit and patterned tie smiling with a neutral gray background.

Dr. Hoover is a rheumatologist and translational scientist specializing in autoimmune diseases. As Director of Translational Research in Lupus Nephritis at Brigham and Women’s Hospital, he studies immune responses and macrophage roles in tissue damage and repair. He earned his MD and PhD in molecular and cellular physiology from Stanford and completed his rheumatology training at Brigham and Women’s, conducting postdoctoral research at the Broad Institute of MIT and Harvard.

Wonhee Han, PhD Post-doctoral scholar

Wonhee Han, PhD Post-doctoral scholar

Wonhee Han, PhD Post-doctoral scholar

Man with glasses wearing a green and blue checkered shirt.

Dr. Han is a post-doctoral researcher studying macrophage-stromal interactions that drive repair and injury in lupus nephritis. His work includes developing LN-associated macrophage and 3D kidney models for personalized lupus nephritis research. He utilizes CRISPR-Cas9 genetic screening to identify key regulators involved in macrophage differentiation and activation.

Antara Roy, PhD Post-doctoral schoar

Wonhee Han, PhD Post-doctoral scholar

Antara Roy, PhD Post-doctoral schoar

Dr. Roy is a postdoctoral researcher investigating injury‑associated monocytes and macrophages in autoimmune disease. Using mouse models of lupus nephritis, she employs genetic, pharmacologic, and antibody‑mediated approaches to perturb these cells and define their impact on immune responses and disease progression.

Haniya Kamal, MS Bioinformatician

Megan Hanlon, PhD Associate researcher

Antara Roy, PhD Post-doctoral schoar

Haniya's is a bioinformatician who studies the immune response in kidney tissue and is focused and identifying patterns of injury and repair. Her work uses single cell approaches and clinical data.

Raghav Sharma, MS Bioinformatician

Megan Hanlon, PhD Associate researcher

Megan Hanlon, PhD Associate researcher

Young man with glasses smiling against a grey brick wall.

Raghav is a Bioinformatician in the Hoover and Gravallese Labs, where his research focuses on autoimmune diseases, particularly lupus nephritis and rheumatoid arthritis. By utilizing both human data and mouse models, he aims to uncover shared disease mechanisms related to lupus nephritis. His work integrates bulk and single-cell multiomics with spatial transcriptomics to identify disease drivers, map altered molecular pathways, and enhance our understanding of immune changes, particularly the role of macrophages in inflammation and tissue repair. Additionally, he highlights potential therapeutic targets for treating these conditions.

Megan Hanlon, PhD Associate researcher

Megan Hanlon, PhD Associate researcher

Megan Hanlon, PhD Associate researcher

Smiling woman with long brown hair wearing a mustard yellow top against a gray background.

Megan is an Instructor in Medicine at Brigham and Women’s Hospital, Harvard Medical School, and an ANRF Gale “Morrie” Granger Fellow. She is a translational rheumatology researcher specializing in myeloid functions in Rheumatoid Arthritis, with interests in immunometabolism and early disease biomarkers. Megan earned her BSc in Biomedical, Health, and Life Sciences from University College Dublin and completed her PhD at Trinity College Dublin as an Irish Research Council Scholar. In 2022, she joined Harvard’s Gravallese lab as a visiting research fellow and now as a postdoctoral fellow, studying SPP1+ macrophages and the joint microenvironment's impact on trained immunity. She aims to further explore the interactions between metabolism, bone, and the immune system in RA. She is a research associate with in the Hoover Lab, providing important insights into macrophage.

SELECTED PUBLICATIONS

Spatially Distinct Macrophage Subsets Drive Myofibroblast Heterogeneity and Maladaptive Fibrosis in Lupus Nephritis
Chirag Raparia, Paul J. Hoover, Junting Ai, Marcus Clark, Sujal Shah, Accelerating Medicines Partnership (AMP) RA/SLE Network, Betty diamond, Nir Hacohen, Arnon Arazi, Anne Davidson

Published in bioRxiv 2026. doi: https://doi.org/10.64898/2026.04.27.719870

Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression
Hoover PJ
, Eisenhaure T, Hodgin J, Apruzzese W, Mears J, Peters M, Jones T, Shah SI, Kamal H, Leavitt R, Jackson SW, Danaher P, Rao DA, Xiao Q, Gurajala S, Fava A, Berthier CC, Horisberger A, Izmirly PM, Belmont HM, Clancy R, Furie R, Guthridge JM, Dall'Era M, Wofsy D, Kamen DL, Kalunian KC, McMahon MA, Grossman J, Payan-Schober F, Hildeman DM, Woodle ES, Putterman C, Kretzler M, Raychaudhuri S, James JA, Anolik J, Petri MA, Buyon JP, The Accelerating Medicines Partnership RA/SLE Network, Diamond B, Davidson A, Hacohen N, Arazi A.  Ann Rheum Dis. 2026 Apr 28:S0003-4967(26)00149-4. doi: 10.1016/j.ard.2026.03.004. PMID: 42055919

Pregnancy loss due to early developmental defects in lupus mice expressing human TLR8

Naomi I Maria, Yunwei Xia, Chirag Raparia, Ke Lin, Shani Martinez, Zhengzi Yi, Weijia Zhang, Monowar Aziz, Ping Wang, Marta Guerra, Jane Salmon, Jenny L Sones, Arnon Arazi, Paul Hoover, Anne Davidson bioRxiv 2026.02.07.701591; Published in bioRxiv 2026. doi: https://doi.org/10.64898/2026.02.07.701591

A human-mouse atlas of intrarenal myeloid cells identifies conserved disease-associated macrophages in lupus nephritis

Hoover PJ, Raparia C, Lieb DJ, Tzur Y, Kang J, Arazi A, Leavitt R, Shah S, Simmons D, Li S, Peters M, Eisenhaure T, Cooper TJ, Gurajala SS, Xiao Q, Mishra R, Menon R, Kretzler M, Sonny A, Demeke D, Hodgin J, Guthridge J, Fava A, Clancy R, Putterman C, Izmirly P, Belmont HM, Kalunian K, Kamen D, Wofsy D, Buyon J, James JA, Petri M, Diamond B, Raychaudhuri S, Shen Orr SS, The Accelerating Medicines Partnership RA/SLE network, Hacohen N, Davidson A. J Exp Med. 2025 Nov 3;222(11):e20241873. doi: 10.1084/jem.20241873. 

A population-scale atlas of blood and tissue in lupus nephritis 

Siddarth Gurajala, Nicholas Sugiarto, Michelle Curtis, Tom Eisenhaure, Arnon Arazi, Andrea Fava, Qian Xiao, Joseph Mears, Brad Rovin, Celine C. Berthier, Peter Izmirly, Jennifer Barnas, Paul J. Hoover, Michael Peters, Raktima Raychowdhury, Alice Horsberger, Saori Sakaue, Yu Zhao, Richard A. Furie, Michael Belmont, Dave Hildeman, E. Steve Woodle, Maria Dall’Era, Chaim Putterman, Diane L. Kamen, Maureen A. McMahon, Jennifer Grossman, Ken Kalunian, Jeffrey Hodgin, Fernanda Payan-Schober, William Apruzzese, Harris Perlman, Carla M. Cuda, David Wofsy, Joel M. Guthridge, Jennifer H. Anolik, Judith A. James, Accelerating Medicines Partnerships Rheumatoid Arthritis/Systemic Lupus Erythematosus, Deepak A. Rao, Anne Davidson, Michelle A. Petri, Jill P. Buyon, Nir Hacohen, Betty Diamond, Soumya Raychaudhuri. Published in bioRxiv on 2025.08.11.669754. doi: doi.org/10.1101/2025.08.11.669754.

An atlas of healthy and injured cell states and niches in the human kidney 

Blue B Lake, Rajasree Menon, Seth Winfree, Qiwen Hu, Ricardo Melo Ferreira, Kian Kalhor, Daria Barwinska, Edgar A Otto, Michael Ferkowicz, Dinh Diep, Nongluk Plongthongkum, Amanda Knoten, Sarah Urata, Laura H Mariani, Abhijit S Naik, Sean Eddy, Bo Zhang, Yan Wu, Diane Salamon, James C Williams, Xin Wang, Karol S Balderrama, Paul J Hoover, Evan Murray, Jamie L Marshall, Teia Noel, Anitha Vijayan, Austin Hartman, Fei Chen, Sushrut S Waikar, Sylvia E Rosas, Francis P Wilson, Paul M Palevsky, Krzysztof Kiryluk, John R Sedor, Robert D Toto, Chirag R Parikh, Eric H Kim, Rahul Satija, Anna Greka, Evan Z Macosko, Peter V Kharchenko, Joseph P Gaut, Jeffrey B Hodgin, KPMP Consortium, Michael T Eadon, Pierre C Dagher, Tarek M El-Achkar, Kun Zhang, Matthias Kretzler, Sanjay Jain Published in Nature, Volume 619, Pages 585–594 (2023), the research provides a detailed examination of the cellular landscape in the human kidney, paving the way for advancements in treatment strategies.

The immune cell landscape in the kidneys of patients with lupus nephritis  

Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li S, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, Sutherby D, Steelman S, Smilek DE, Tosta P, Apruzzese W, Massarotti E, Dall'Era M, Park M, Kamen DL, Furie RA, Payan-Schober F, Pendergraft WF, McInnis EA, Buyon JP, Petri MA, Putterman C, Kalunian KC, Woodle ES, Lederer JA, Hildeman DA, Nusbaum C, Raychaudhuri S, Kretzler M, Anolik JH, Brenner MB, Wofsy D, Hacohen N, and Diamond B, was published in Nat Immunol. 2019 07; 20(7):902-914. PMID: 31209404.

SUPPORT

CONTACT US

Get in Touch!

Attach Files
Attachments (0)

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Questions/comments or interested in joining our team?

Send us a message using this form to discuss topics related to autoimmune diseases, including the role of macrophages, and various therapeutic targets. We are always looking for passionate post-docs, graduate students, research assistants, and undergrads. Please send your application and CV to phoover@bwh.harvard.edu.

The Hoover Lab

Hale Building for Transformative Medicine at Brigham and Women's Hospital, 60 Fenwood Rd, Boston, MA 02115, USA


Copyright © 2026 The Hoover Lab - All Rights Reserved.


Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept